Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKinsey
Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: March 30, 2023

Patent: 8,809,507


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions


Summary for Patent: 8,809,507
Title:SPARC binding ScFvs
Abstract: The invention provides compositions comprising SPARC binding ScFc and its use.
Inventor(s): Trieu; Vuong (Agoura Hills, CA)
Assignee:
Application Number:13/132,455
Patent Claims:see list of patent claims

Details for Patent 8,809,507

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 01/10/1978 ⤷  Sign Up 2028-12-05
Genentech, Inc. RITUXAN rituximab Injection 103705 11/26/1997 ⤷  Sign Up 2028-12-05
Idec Pharmaceuticals Corp. RITUXAN rituximab Injection 103737 02/19/2002 ⤷  Sign Up 2028-12-05
Genentech, Inc. RITUXAN HYCELA rituximab and hyaluronidase human Injection 761064 06/22/2017 ⤷  Sign Up 2028-12-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Merck
AstraZeneca
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.